Nurix Therapeutics reports $87.2 million Q1 loss amid drug trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. TTEC
5. DAL
6. AWK
7. SPCX
8. III
9. TEVA
10. FCLI

Go back to Nurix Therapeutics reports $87.2 million Q1 loss amid drug trials
(NASDAQ: NRIX) Delayed: 17.55 +0.43 (2.51%)
Previous Close $17.12    52 Week High $ 
Open $17.64    52 Week Low $ 
Day High $17.89    P/E N/A 
Day Low $16.95    EPS $ 
Volume 4,250,981